Physician profile

Haroon Ashraf

Dentist · Mesa, AZ

NPI 1821481250

$713.68

in general payments reported to CMS, 2019-2025

9 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Education$100.00
Entertainment$75.71
Food and Beverage$56.99

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Nobel Biocare USA $218.53 2019-2023 Nobelactive
Straumann USA LLC $198.49 2024
Salvin Dental Specialties, INC. $130.30 2020
Dentsply Sirona INC $51.63 2020-2022
Philips North America LLC $34.75 2019
Kerr Corporation $33.26 2020
Henry Schein, INC. $17.19 2024
Gc America INC. $15.90 2021
Zimmer Biomet Holdings, INC. $13.63 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Haroon Ashraf

$713.68

in general payments reported 2019-2025

Years
2019-2024
Top company
Nobel Biocare USA

https://glasscript.com/doctor/1365619/haroon-ashraf

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.